“…Clinical parametersTotal n=32 Age, cohort median , yrs (IQR)11.5[6][7][8][9][10][11][12][13][14][15] Age 1yr, n(%) 1 (3%) Age >1 and 10 yrs, n(%) 10 (31%) Age >10 and < 18 yrs, n(%) 21 (66%) Positive family history, n (%) Nodal rhythm, n (%) 2 (6%) WPW, n (%) 1 (3%) RBBB, n (%) 1 (3%) LBBB, n (%) 0 (0%) LV overload, n (%)4 = 2.3 -6.24, n (%) 24 (82%) NC/C = 1.2 -2.1, n (%) 5 (17%) Pharmacological treatment , n (%) 22 (69%) Beta-blockers, n (%) 9 (28%) ACE-I, n (%) 19 (59%) Furosemide, n (%) 1 (3%) Spironolaktone, n (%) 16 (50%) Acetylsalicylic acid, n (%) 3 (9%) Acenokumarol, n (%) 1 (3%) Salbutamol, n (%) 4 (13%) Other procedures, n (%) 6 (19%) Electrophysiological study , n (%) 1 (3%) RF ablation , n (%) 1 (3%) Pacemaker, n (%) 2 (6%) LVAD, n (%) 1 (3%) W/L for HTx, n (%) 1 (3%) Death, n (%) 1 (3%) HF -heart failure; SCD -sudden cardiac death; CTR -cardiothoracic ratio; NC/C -noncompaction to compaction layer ratio; EF -ejection fraction; RBBB -right bundle branch block;, LBBB -left bundle branch block; EPSelectrophysiology study; ablation RF -radiofrquency ablation; LVAD -left ventricular assist device; LVNC -left ventricular noncompaction cardiomyopathy; HCM -hypertrophic cardiomyopathy;, DCM -Dilated cardiomyopathy; WPW -Wolff-Parkinson-White syndrome;, AVNRT -Atrioventricular nodal reentry tachycardia.…”